Zink Biomed 20
Zink Biomed 20 is a medicine authorised by Swissmedic under authorisation number 55476. The authorisation holder is Biomed AG. The medicinal product code is Synthetic medicines and the dispensing category is B/D: The medicine has strengths in category B and in category D, so supply depends on the strength. First authorisation was granted on 06 June 2003 and the authorisation is valid without a time limit. ATC code A12CB02 places the medicine in the group Mineral supplements.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Zink Biomed 20, Filmtabletten | B | 06 June 2003 |
| 3 | Zink Biomed 10, Filmtabletten | D | 09 January 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 50 | Tablette(n) | A12CB02 | 07.02.1. | B |
| 6 | 50 | Tablette(n) | A12CB02 | 07.02.1. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Zink Biomed 20 authorised in Switzerland?
Yes. Zink Biomed 20 is authorised by Swissmedic under authorisation number 55476, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Zink Biomed 20 have?
Zink Biomed 20 is in dispensing category B/D. The medicine has strengths in category B and in category D, so supply depends on the strength.
Who is the authorisation holder of Zink Biomed 20?
The authorisation holder is Biomed AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.